Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2002 13
2003 13
2004 19
2005 17
2006 23
2007 32
2008 37
2009 33
2010 43
2011 61
2012 72
2013 94
2014 118
2015 139
2016 148
2017 155
2018 173
2019 219
2020 295
2021 319
2022 373
2023 417
2024 453
2025 508
2026 114

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,450 results

Results by year

Filters applied: . Clear all
Page 1
Individualized patient tumor organoids faithfully preserve human brain tumor ecosystems and predict patient response to therapy.
Peng T, Ma X, Hua W, Wang C, Chu Y, Sun M, Fermi V, Hamelmann S, Lindner K, Shao C, Zaman J, Tian W, Zhuo Y, Harim Y, Stöffler N, Hammann L, Xiao Q, Jin X, Warta R, Lotsch C, Zhuang X, Feng Y, Fu M, Zhang X, Zhang J, Xu H, Qiu F, Xie L, Zhang Y, Zhu W, Du Z, Salgueiro L, Schneider M, Eichhorn F, Lefevre A, Pusch S, Grinevich V, Ratliff M, Loges S, Bunse L, Sahm F, Xiang Y, Unterberg A, von Deimling A, Platten M, Herold-Mende C, Wu Y, Liu HK, Mao Y. Peng T, et al. Among authors: xu h. Cell Stem Cell. 2025 Apr 3;32(4):652-669.e11. doi: 10.1016/j.stem.2025.01.002. Epub 2025 Feb 11. Cell Stem Cell. 2025. PMID: 39938519 Free article.
Immune cell landscape in a human decedent receiving a pig liver xenograft.
Tao KS, Ling YW, Zhang X, Yang ZX, Zhang HT, Yue SQ, Yang YL, Song WJ, Wang DS, Liu ZC, Li HM, Chen Y, Ding R, Li L, Li M, Lin ZB, Xu H, Wei D, Zhang H, Duan JL, Zhuang R, Long EW, Zhou L, Pan DK, Dou KF, Wang L. Tao KS, et al. Among authors: xu h. Nat Med. 2025 Aug;31(8):2611-2621. doi: 10.1038/s41591-025-03860-y. Epub 2025 Jul 30. Nat Med. 2025. PMID: 40739423
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial.
Shi Y, Han G, Zhou J, Shi X, Jia W, Cheng Y, Jin Y, Hua X, Wen T, Wu J, Gu S, Bai Y, Wang X, Zhang T, Chen Z, Zhang B, Huang M, Liu H, Mao Y, Zhou L, Wang R, Shan Y, Zhang W, Song T, Guo Y, Zhou F, Shao B, Zhang M, Liang B, Zheng J, Zhang G, Shen J, Su W, Zhang F, He Y, Hu S, Liu R, Zhang C, Shen S, Zeng H, Wang TE, Guo W, Shen Y, Chen Y, Li Y, Samol J, Hu H, Zhang W, Du C, Li E, Liu C, Pin CS, Li X, Xu H, Huang JF, Hao C, Lv J, Wang W, Xu Q, Bai A, Zhang X, Liu B, Jin C, Fan J. Shi Y, et al. Among authors: xu h. Lancet Gastroenterol Hepatol. 2025 Jul;10(7):658-670. doi: 10.1016/S2468-1253(25)00059-7. Epub 2025 May 20. Lancet Gastroenterol Hepatol. 2025. PMID: 40409323 Clinical Trial.
3,450 results